Used as an intermediate in the synthesis of certain pharmaceutical compounds, particularly in the development of prostaglandin analogs. These analogs are often utilized in ophthalmic medications for the treatment of glaucoma, helping to reduce intraocular pressure. The compound's structure allows for specific modifications that enhance drug stability and receptor selectivity. It may also serve in research settings for exploring cyclopropane-containing bioactive molecules.